A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM) (NCT06464588)
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a Phase 1 study to determine the safety and efficacy of allogeneic neonatal mesenchymal stromal cells (nMSCs) for the treatment of Dilated Cardiomyopathy. The purpose of the study is to help doctors and scientists learn if allogeneic neonatal mesenchymal stromal cells (nMSCs) infusions are a safe and effective way to improve cardiac function and left ventricular ejection fraction.
Who can join: Review the eligibility criteria below.
Location: Grady Memorial Hospital โ Atlanta, Georgia
Age range: 4 Years to 40 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (5 Sites)
- Grady Memorial Hospital โ Atlanta, Georgia
- Hughes Spalding Children's Hospital โ Atlanta, Georgia
- Emory University Hospital โ Atlanta, Georgia
- Arthur M. Blank Hospital โ Atlanta, Georgia
- Scottish Rite Children's Hospital โ Atlanta, Georgia
๐ Contact the Study Coordinator
Phone: (404) 256-2593
Email: wmahle@emory.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dilated Cardiomyopathy
- Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study โ Columbus, Ohio
- Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT) โ Lancaster, Pennsylvania
Explore by condition: All Dilated Cardiomyopathy clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.